BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30843648)

  • 1. Renal medullary carcinoma in a young mixed-race man in Japan.
    Toriyama A; Izumi H; Tomita S; Nagashima Y; Ueda Y; Aoki Y; Tsujimura A; Yao T; Hino O
    Pathol Int; 2019 Apr; 69(4):241-245. PubMed ID: 30843648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Medullary Carcinoma Associated with Sickle Cell Trait.
    Frazier AA
    Radiographics; 2017; 37(5):1537. PubMed ID: 28898179
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.
    Brown JM; Berkey BD; Brooks JA
    Clin Nucl Med; 2008 Dec; 33(12):896-900. PubMed ID: 19033803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1 inactivation in renal medullary carcinoma.
    Calderaro J; Moroch J; Pierron G; Pedeutour F; Grison C; Maillé P; Soyeux P; de la Taille A; Couturier J; Vieillefond A; Rousselet MC; Delattre O; Allory Y
    Histopathology; 2012 Sep; 61(3):428-35. PubMed ID: 22686875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
    Lai JZ; Lai HH; Cao D
    Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
    Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
    Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Renal Medullary Carcinoma.
    Su Y; Hong AL
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.
    Wei D; Yang Y; Ricketts CJ; Vocke CD; Ball MW; Sourbier C; Wangsa D; Wangsa D; Guha R; Zhang X; Wilson K; Chen L; Meltzer PS; Ried T; Thomas CJ; Merino MJ; Linehan WM
    Genes Chromosomes Cancer; 2020 Aug; 59(8):472-483. PubMed ID: 32259323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal medullary carcinoma in a white adolescent with sickle cell trait.
    Daher P; Bourgi A; Riachy E; Khoury A; Rehayem C; Sader-Ghorra C
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e285-9. PubMed ID: 24517963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
    Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
    Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
    Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
    Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.
    Carlo MI; Chaim J; Patil S; Kemel Y; Schram AM; Woo K; Coskey D; Nanjangud GJ; Voss MH; Feldman DR; Hsieh JJ; Hakimi AA; Chen YB; Motzer RJ; Lee CH
    Clin Genitourin Cancer; 2017 Dec; 15(6):e987-e994. PubMed ID: 28558987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
    Msaouel P; Malouf GG; Su X; Yao H; Tripathi DN; Soeung M; Gao J; Rao P; Coarfa C; Creighton CJ; Bertocchio JP; Kunnimalaiyaan S; Multani AS; Blando J; He R; Shapiro DD; Perelli L; Srinivasan S; Carbone F; Pilié PG; Karki M; Seervai RNH; Vokshi BH; Lopez-Terrada D; Cheng EH; Tang X; Lu W; Wistuba II; Thompson TC; Davidson I; Giuliani V; Schlacher K; Carugo A; Heffernan TP; Sharma P; Karam JA; Wood CG; Walker CL; Genovese G; Tannir NM
    Cancer Cell; 2020 May; 37(5):720-734.e13. PubMed ID: 32359397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases.
    Miller DL; Ribeiro EA; Roy-Chowdhuri S; Illei PB; Siddiqui MT; Ali SZ
    J Am Soc Cytopathol; 2021; 10(2):187-196. PubMed ID: 32651128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.
    Holland P; Merrimen J; Pringle C; Wood LA
    Curr Oncol; 2020 Feb; 27(1):e53-e56. PubMed ID: 32218668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal medullary carcinoma metastatic to the orbit: a clinicopathologic report.
    Zdinak LA; Nik NA; Hidayat AA; Hargett NA
    Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):322-5. PubMed ID: 15266151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.
    Carter SA; Walker AN
    J Natl Med Assoc; 2017 Spring; 109(1):63-65. PubMed ID: 28259220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
    Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; De Nictolis M; Santoni M; Montironi R
    Pathology; 2014 Dec; 46(7):653-5. PubMed ID: 25393261
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal medullary carcinoma in a six-year-old boy with sickle cell trait.
    Vargas-Gonzalez R; Sotelo-Avila C; Coria AS
    Pathol Oncol Res; 2003; 9(3):193-5. PubMed ID: 14530815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
    Jia L; Carlo MI; Khan H; Nanjangud GJ; Rana S; Cimera R; Zhang Y; Hakimi AA; Verma AK; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Gartrell BA; Chen YB
    Mod Pathol; 2019 Sep; 32(9):1329-1343. PubMed ID: 30980040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.